The renin‐angiotensin system is upregulated in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis
Authors:
- Ana Carla KonnoAKAna Carla Konno
- Sandra Regina PerosaSPSandra Regina Perosa
- Joselita Ferreira Carvalho SantiagoJSJoselita Ferreira Carvalho Santiago
- Mirian A BoimMBMirian A Boim
- Daniela Berguio VidottiDVDaniela Berguio Vidotti
- Pedro Paulo Vasconcelos VarellaPVPedro Paulo Vasconcelos Varella
- Luciana Gilbert CostaLCLuciana Gilbert Costa
- Mauro CanzianMCMauro Canzian
- Marimélia Aparecida PorcionattoMPMarimélia Aparecida Porcionatto
- Elza Márcia YacubianEYElza Márcia Yacubian
- Américo Ceiki SakamotoASAmérico Ceiki Sakamoto
Open Access
Abstract
Summary: Purpose: As reported by several authors, angiotensin II (AngII) is a proinflammatory molecule that stimulates the release of inflammatory cytokines and activates nuclear factor κB (NFκB), being also associated with the increase of cellular oxidative stress. Its production depends on the activity of the angiotensin converting enzyme (ACE) that hydrolyzes the inactive precursor angiotensin I (AngI) into AngII. It has been suggested that AngII underlies the physiopathological mechanisms of several brain disorders such as stroke, bipolar disorder, schizophrenia, and disease. The aim of the present work was to localize and quantify AngII AT1 and AT2 receptors in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis (MTS) submitted to corticoamygdalohippocampectomy for seizure control. Method: Immunohistochemistry, Western blot, and real‐time PCR techniques were employed to analyze the expression of these receptors. Results: The results showed an upregulation of AngII AT1 receptor as well as its messenger ribonucleic acid (mRNA) expression in the cortex and hippocampus of patients with MTS. In addition, an increased immunoexpression of AngII AT2 receptors was found only in the hippocampus of these patients with no changes in its mRNA levels. Discussion: These data show, for the first time, changes in components of renin‐angiotensin system (RAS) that could be implicated in the physiopathology of MTS.Keywords
This publication has 31 references indexed in Scilit:
- Kinin B1 and B2 receptors are overexpressed in the hippocampus of humans with temporal lobe epilepsyHippocampus, 2006
- Involvement of the somatostatin‐2 receptor in the anti‐convulsant effect of angiotensin IV against pilocarpine‐induced limbic seizures in ratsJournal of Neurochemistry, 2006
- Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortexBrain, 2006
- Brain Angiotensin II: New Developments, Unanswered Questions and Therapeutic OpportunitiesCellular and Molecular Neurobiology, 2005
- Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell deathBrain Research, 2005
- Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility?Life Sciences, 2005
- The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memoryProgress in Neurobiology, 2004
- Neural plasticity and the brain renin–angiotensin systemNeuroscience & Biobehavioral Reviews, 2002
- Monoamines and their metabolites in cerebrospinal fluid and temporal cortex of epileptic patientsEpilepsy Research, 1996
- The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cellsMolecular and Cellular Endocrinology, 1996